ArticleBiomedicines2022

Macrophage C/EBPδ Drives Gemcitabine, but Not 5-FU or Paclitaxel, Resistance of Pancreatic Cancer Cells in a Deoxycytidine-Dependent Manner.

C Arnold Spek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.